Sectoral Asset Management Inc Halozyme Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$37.81 - $52.4 $70,515 - $97,726	-1,865 Reduced 32.83%	3,815 $199,000
Q1 2024 May 14, 2024	SELL	$33.68 - $41.95 $11,788 - $14,682	-350 Reduced 5.8%	5,680 $231,000
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $4.66 Million - $5.89 Million	-139,970 Reduced 95.87%	6,030 $222,000
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $239,286 - $288,968	6,563 Added 4.71%	146,000 $5.58 Million
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $667,280 - $853,713	22,037 Added 18.77%	139,437 $5.03 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $657,200 - $1.11 Million	-20,000 Reduced 14.56%	117,400 $4.48 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $269,710 - $362,460	7,000 Added 5.37%	137,400 $5.43 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $164,340 - $212,520	4,400 Added 3.49%	130,400 $5.74 Million
Q1 2022 May 10, 2022	BUY	$31.97 - $41.06 $4.03 Million - $5.17 Million	126,000 New	126,000 $5.03 Million
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $535,392 - $616,304	-20,800 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $338,000 - $557,648	20,800 New	20,800 $558,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.